Skip to main content
Log in

Highly potent and selective ligands for histamine H3-receptors

  • Article
  • Published:

From Nature

View current issue Submit your manuscript

Abstract

New drugs selective for histamine H3-receptors can be used to establish that these receptors are involved in the feedback control ofhistamine synthesis and release, and to demonstrate their distribution in the brain and peripheral tissues. These drugs provide new tools for affecting physiological and possibly pathological conditions in which histamine is involved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. 1. Plaut, M. & Lichtenstein, L. M. in Pharmacology of Histamine Receptors (eds Ganellin, C. R. & Parsons, M. E.) 392–435 (Wright PSG, Bristol 1982). 2. Hakanson, R. & Owman, C. Life Sci. 6, 759–766 (1967). 3. Schwartz, J.-C., Garbarg, M. & Pollard, H. in Handbook of Physiology, the Nervous System, Vol. IV: Intrinsic Regulatory Systems of the Brain (eds Bloom, F. E., Mountcastle, W. B. & Geiger, S. R.) 257–316 (American Physiological Society, Bethesda, 1986). 4. Happola, O., Soinila, S., Paivarinta, H., Panula, P. & Eranko- d. Histochemistry 82, 1–3 (1985). 5. Berridge, M. J. & Irvine, R. F. Nature 312, 315–321 (1984). 6. Hegstrand, L. R., Kanof, P. D. & Greengard, P. Nature 260, 163–165 (1976). 7. Black, J. W., Duncan, W. A. M., Durant, C. J., Ganellin, C. R. & Parsons, M. E. Nature 236,385–390(1972). 8. Arrang, J.-M., Garbarg, M. & Schwartz, J.-C. Nature 302, 832–837 (1983). 9. Arrang, J.-M., Garbarg, M. & Schwartz, J.-C. Neuroscience 15, 553–562 (1985). 10. Arrang, J.-M., Garbarg, M. & Schwartz, J.-C. in Frontiers in Histamine Research (eds Ganellin, C. R. & Schwartz, J.–C.) 143–153 (Pergamon, Oxford, 1985). 11. Ganellin, C. R. in Pharmacology of Histamine Receptors (ed Ganellin, C. R. & Parsons, M. E.) 10–102 (Wright PSG, Bristol, 1982). 12. Schunack, W., Schwarz, S., Gerhard, G., Buyiiktimkin, S. & Elz, S. in Frontiers in Histamine Research (eds Ganellin, C. R. & Schwartz, J.-C) 39–46 (Pergamon, Oxford, 1985). 13. Arrang, J.-M., Schwartz, J.-C. & Schunack, W. Eur. J. Pharmac. 117, 109–114 (1985). 14. Schwartz, J.-C., Arrang, J.-M., Garbarg, M. & Korner, M. J. exp. Biol. 124, 203–224 (1986). 15. Arrang, J.-M. et al. Eur. J. Pharmac. Ill, 73–84 (1985). 16. Gaddum, J. H. / PhysioL, Lond. 89. 7P–9P (1937). 17. Cheng, Y. C. & Prusoff, W. H. Biochem. Pharmac. 22, 3099–3108 (1973). 18. Baudry, M., Martres, M. P. & Schwartz, J.-C. Brain Res. 116, 111–124 (1976). 19. U'Prichard, D. C., Greenberg, D. A. & Snyder, S. H. Molec. Pharmac. 13, 454–473 (1977). 20. Yamamura, H. I. & Snyder, S. H. Molec. Pharmac. 10, 861–867 (1974). 21. Pert, C. B. & Snyder, S. H. Science 179, 1011–1014 (1973). 22. Martres, M. P., Bouthenet, M. L., Sales, N., Sokoloff, P. & Schwartz, J.-C. Science 228, 752–755 (1985). 23. Peroutka, S. J. & Snyder, S. H. Molec. Pharmac. 16, 687–699 (1979). 24. Leysen, J. E., Niemegeers, C. J. E., Tollenaere, J. P. & Laduron, P. M. Nature 272,168–171 (1978). 25. Schwartz, J.-C., Arrang, J.-M., Garbarg, M. & Schunack, W. in Innovative Approaches in Drug Research (ed. Harms, A. F.) 73–89 (Elsevier, Amsterdam, 1986). 26. Garbarg, M., Barbin, G., Rodergas, E. & Schwartz, J.-C. /. Neurochem. 35,1045–1052 (1980). 27. Watanabe, T. et al. Neurosci. Lett. 39, 249–254 (1983). 28. Steinbusch, H. W. M. & Mulder, A. H. in Frontiers in Histamine Research (eds Ganellin, C. R. & Schwartz, J.-C.) 119–130 (Pergamon, Oxford, 1985). 29. Eyre, P. & Chand, N. in Pharmacology of Histamine Receptors (eds Ganellin, C. R. & Parsons, M. E.) 298–322 (Wright PSG, Bristol, 1982). 30. Pearce, F. L. et al. in Frontiers in Histamine Research (eds Ganellin, C. R. & Schwartz, J.-C.) 411–422 (Pergamon, Oxford, 1985). 31. Hill, S. J., Emson, P. C. & Young, J. M. /. Neurochem. 31, 997–1004 (1978). 32. Tran, V. T., Chang, R. S. L. & Snyder, S. H. Proc. natn. Acad. Sci. U.S.A. 75,6290–6294 (1978). 33. Gajtkowski, G. A., Norris, D. B., Rising, T. J. & Wood, T. P. Nature 304, 65–67 (1983). 34. Langer, S. Z. Br. J. Pharmac. 60, 481–497 (1977). 35. Starke, K. A. Rev. Pharmac. Tox. 21, 7–30 (1981). 36. Stjarne, L. in Chemical Neurotransmission 75 Years. Karolinska Institutet, Nobel Conference No. 2 (eds Stjarne, L., Hedqvist, P., Lagercrantz, H. & Wennmalm, A.) 257–272 (Academic, London, 1981). 37. Schoffelmeer, A. N. M., Wierenga, E. A. & Mulder, A. H. / Neurochem. 46, 1711–1717 (1986). 38. Schwartz, J.-C. A. Rev. Pharmac. Tox. 17, 325–339 (1977). 39. Vanni-Mercier, G., Sakai, K. & Jouvet, M. C.r. hebd. Seanc. Acad. Sci., Paris 298, 195–200 (1984). 40. Lin, J.-S., Sakai, K. & Jouvet, M. C.R. hebd. Seanc. Acad. Sci., Paris 303, 469–474 (1986). 41. Gross, P. M. in Frontiers in Histamine Research (eds Ganellin, C. R. & Schwartz, J.-C.) 341–352 (Pergamon, Oxford, 1985). 42. Quach, T. T., Duchemin, A. M., Rose, C. & Schwartz, J.-C. Molec. Pharmac. 17, 301–308 (1980). 43. Tuomisto, J. & Mannisto, P. Pharmac. Rev. 37, 249–332 (1985). 44. Gerhard, G. & Schunack, W. Arch. Pharm., Weinheim 313, 709–714 (1980). 45. Schunack, W. Arzneimittel-Forsch. 28, 2199–2202 (1978). 46. Kollonitsch, J. et al. Nature 274, 906–908 (1978). 47. Garbarg, M., Pollard, H., Quach, T. T. & Schwartz, J.-C. in Methods in Biogenic Amines Research (eds Parvez, S., Nagatsu, T., Nagatsu, I. & Parvez, H.) 623–662 (Elsevier, Amsterdam, 1983). 48. Saeki, K., Oishi, R. & Nishibori, M. in Frontiers in Histamine Research (eds Ganellin, C. R. & Schwartz, J.-C.) 173–184 (Pergamon, Oxford, 1985). 49. Parker, R. B. & Waud, D. R. J. Pharmac. exp. Therap. 177, 1–12 (1971). 50. Paxinos, G. & Watson, C. The Rat Brain in Stereotaxic Coordinates (Academic, London, 1982).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arrang, JM., Garbarg, M., Lancelo, JC. et al. Highly potent and selective ligands for histamine H3-receptors. Nature 327, 117–123 (1987). https://doi.org/10.1038/327117a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/327117a0

  • Springer Nature Limited

This article is cited by

Navigation